Atiyeh Dabouian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Atiyeh Dabouian has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ali Salimi Jeda
Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 shared publications - Fahimeh Safarnezhad Tameshkel
Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran
2 shared publications Hossein Keyvani
Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran
2 shared publications- Mohammad Hadi Karbalaie Niya
Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran
2 shared publications Ahmad Tavakoli
Research Center of Pediatric Infectious Diseases, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran
1 shared publication- Alireza Tabibzadeh
Rajaei Clinical Research Development Unit (CRDU) of Shahid Rajaei Hospital, Alborz University of Medical Sciences, Karaj, Iran
1 shared publication
Latest Publications
- 24 May 2026
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
Molecular And Clinical Significance of PDGFR Family in Papillary Thyroid Cancer: A Systematic Review
Objective: Papillary thyroid cancer (PTC) is the most prevalent endocrine cancer. Activation of platelet-derived growth factor receptors (PDGFRs) is involved in the development of thyroid cancers. This systematic review aims to evaluate the molecular and clinical significance of PDGFRs in PTC. Method: A comprehensive literature search was performed in PubMed, Scopus, and Web of Science databases up to August 2024, focusing on studies evaluating PDGFRα/β variants, expression levels, and clinical outcomes in PTC. Eligible studies were selected according to PRISMA guideline. Studies including unknown histology, insufficient data, case reports, non-human experiments, and review article were excluded. The REMARK criteria were applied for quality assessment of the included studies. Results: A total of twelve studies were included. Genetic alterations in the promoter of PDGFRα (rs6554162 and rs1800812) showed a significant association with increased risk of PTC, while synonymous variants were more frequently detected in benign tumors. In contrast, noncoding variants in PDGFRβ showed no association with PTC. Overexpression of PDGFRα was significantly associated with lymph node metastasis, larger tumor size, poorer disease-free survival (DFS) with some inconsistency and poor response to radioactive iodine therapy. Findings on PDGFRβ expression were inconsistent. However, one study reported its upregulation in metastatic PTC and its association with shorter overall survival in patients with BRAFV600E. Conclusion: PDGFRα may serve as a potential biomarker associated with aggressive tumor behavior and treatment failure in people with PTC. Further experimental studies are needed to validate the results. Targeting PDGFRα may represent a therapeutic approach, but evidence is still insufficient.
- 24 May 2026
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
Molecular And Clinical Significance of PDGFR Family in Papillary Thyroid Cancer: A Systematic Review
Objective: Papillary thyroid cancer (PTC) is the most prevalent endocrine cancer. Activation of platelet-derived growth factor receptors (PDGFRs) is involved in the development of thyroid cancers. This systematic review aims to evaluate the molecular and clinical significance of PDGFRs in PTC. Method: A comprehensive literature search was performed in PubMed, Scopus, and Web of Science databases up to August 2024, focusing on studies evaluating PDGFRα/β variants, expression levels, and clinical outcomes in PTC. Eligible studies were selected according to PRISMA guideline. Studies including unknown histology, insufficient data, case reports, non-human experiments, and review article were excluded. The REMARK criteria were applied for quality assessment of the included studies. Results: A total of twelve studies were included. Genetic alterations in the promoter of PDGFRα (rs6554162 and rs1800812) showed a significant association with increased risk of PTC, while synonymous variants were more frequently detected in benign tumors. In contrast, noncoding variants in PDGFRβ showed no association with PTC. Overexpression of PDGFRα was significantly associated with lymph node metastasis, larger tumor size, poorer disease-free survival (DFS) with some inconsistency and poor response to radioactive iodine therapy. Findings on PDGFRβ expression were inconsistent. However, one study reported its upregulation in metastatic PTC and its association with shorter overall survival in patients with BRAFV600E. Conclusion: PDGFRα may serve as a potential biomarker associated with aggressive tumor behavior and treatment failure in people with PTC. Further experimental studies are needed to validate the results. Targeting PDGFRα may represent a therapeutic approach, but evidence is still insufficient.
- Open Access
- 28 April 2021
- Published by Brieflands in Journal of Archives in Military Medicine
- Vol. 8 (4)
Human Rhinovirus Molecular Epidemiology and Genotyping in Iranian Military Trainees with Acute Respiratory Symptoms
Background: Human rhinovirus (HRV) is still the most prevalent viral infection in humans and a significant cause of acute respiratory tract infections (ARTIs) in many communities, including military personnel undergoing basic training. Objectives: In this research, we assessed the molecular epidemiology, genotyping, and phylogenetic classification of HRVs in Iranian military trainees with respiratory infections (RI). Methods: For HRV identification and genotyping, respiratory specimens were obtained, and RT-PCR was conducted for genotyping and phylogenetic analysis of HRV utilizing primers for the 5-UTR region. Results: Among 400 Iranian military trainees (average age of 21 ± 4 years, the range of 18 - 57 years) with respiratory infections, HRV was detected in 29 patients (7%) using RT-PCR. The direct sequencing of PCR products from 10 specimens showed that the incidence of type A (n = 5, 50%) was higher than that of type B (n = 4, 40%) and type C (n = 1, 10%). There were no significant associations between HRV and respiratory and clinical symptoms, blood group, and indoor or outdoor conditions (P-value > 0.05). Conclusions: This research was the first to record HRV as a significant cause of respiratory problems among military trainees in Iran, with a frequency of 7%. The most prevalent genotype was HRV-A, which may be applicable in epidemiological and clinical studies, as well as vaccination plans.
- 28 April 2021
- Published by Brieflands in Journal of Archives in Military Medicine
- Vol. 8 (4)
Open AccessHuman Rhinovirus Molecular Epidemiology and Genotyping in Iranian Military Trainees with Acute Respiratory Symptoms
Background: Human rhinovirus (HRV) is still the most prevalent viral infection in humans and a significant cause of acute respiratory tract infections (ARTIs) in many communities, including military personnel undergoing basic training. Objectives: In this research, we assessed the molecular epidemiology, genotyping, and phylogenetic classification of HRVs in Iranian military trainees with respiratory infections (RI). Methods: For HRV identification and genotyping, respiratory specimens were obtained, and RT-PCR was conducted for genotyping and phylogenetic analysis of HRV utilizing primers for the 5-UTR region. Results: Among 400 Iranian military trainees (average age of 21 ± 4 years, the range of 18 - 57 years) with respiratory infections, HRV was detected in 29 patients (7%) using RT-PCR. The direct sequencing of PCR products from 10 specimens showed that the incidence of type A (n = 5, 50%) was higher than that of type B (n = 4, 40%) and type C (n = 1, 10%). There were no significant associations between HRV and respiratory and clinical symptoms, blood group, and indoor or outdoor conditions (P-value > 0.05). Conclusions: This research was the first to record HRV as a significant cause of respiratory problems among military trainees in Iran, with a frequency of 7%. The most prevalent genotype was HRV-A, which may be applicable in epidemiological and clinical studies, as well as vaccination plans.
- Open Access
- 20 July 2020
- Published by Brieflands in International Journal of Cancer Management
- Vol. 13 (7)
The Molecular Epidemiology of Herpes Simplex Virus Type 1 and 2 (HSV-1 and HSV-2) in Head and Neck Cancer (HNC)
Background: Head and neck cancers (HNC) constitute the sixth common type of malignancies worldwide and can affect a wide range of anatomical regions. The role of the herpes simplex virus (HSV) in oral squamous cell carcinoma (OSCC) has been previously investigated. Objectives: The objective of the current study was to evaluate the molecular epidemiology of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in patients with HNC. Methods: A total of 156 patients with HNC were chosen including 90 biopsies and 66 formalin-fixed paraffin-embedded (FFPE) samples. HNC was confirmed and affected different anatomical regions. HSV detection was performed by a polymerase chain reaction (PCR) and HSV typing was assessed by a multiplex PCR. Results: The 156 HNC specimens included 35 (22.4%) larynx, 29 (18.6%) tongue, 6 (3.8%) glands (parotid and tonsil), 12 (7.6%) nasopharynx, 9 (5.7%) pharynx, 33 (21%) vocal cord, 3 (1.9%) palatine, glottis 17 (10.8%), nasal 2 (1.3%), mandibular 4 (2.5%), lip 4 (2.5%), neck 1 (0.6%), and face 1 (0.6%). The mean ± SD of the patients’ age was 60.3 ± 12.65, where 121 (77.1%) were male. The HSV was detected in 4 (2.6%) samples and 75% of HSV positive samples were HSV-1. Conclusions: The rate of HSV infection in Iranian patients with HNC was 2.6% with the majority being HSV-1 (75%). As a preliminary study in Iranian patients with HNC, cancer location was not statistically significant. Further investigations are needed to assess the role of HSV in HNC.
- 20 July 2020
- Published by Brieflands in International Journal of Cancer Management
- Vol. 13 (7)
Open AccessThe Molecular Epidemiology of Herpes Simplex Virus Type 1 and 2 (HSV-1 and HSV-2) in Head and Neck Cancer (HNC)
Background: Head and neck cancers (HNC) constitute the sixth common type of malignancies worldwide and can affect a wide range of anatomical regions. The role of the herpes simplex virus (HSV) in oral squamous cell carcinoma (OSCC) has been previously investigated. Objectives: The objective of the current study was to evaluate the molecular epidemiology of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in patients with HNC. Methods: A total of 156 patients with HNC were chosen including 90 biopsies and 66 formalin-fixed paraffin-embedded (FFPE) samples. HNC was confirmed and affected different anatomical regions. HSV detection was performed by a polymerase chain reaction (PCR) and HSV typing was assessed by a multiplex PCR. Results: The 156 HNC specimens included 35 (22.4%) larynx, 29 (18.6%) tongue, 6 (3.8%) glands (parotid and tonsil), 12 (7.6%) nasopharynx, 9 (5.7%) pharynx, 33 (21%) vocal cord, 3 (1.9%) palatine, glottis 17 (10.8%), nasal 2 (1.3%), mandibular 4 (2.5%), lip 4 (2.5%), neck 1 (0.6%), and face 1 (0.6%). The mean ± SD of the patients’ age was 60.3 ± 12.65, where 121 (77.1%) were male. The HSV was detected in 4 (2.6%) samples and 75% of HSV positive samples were HSV-1. Conclusions: The rate of HSV infection in Iranian patients with HNC was 2.6% with the majority being HSV-1 (75%). As a preliminary study in Iranian patients with HNC, cancer location was not statistically significant. Further investigations are needed to assess the role of HSV in HNC.